Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study

BACKGROUND: Within the OMITERC prospective study (OMIcs application from solid to liquid biopsy for a personalised ThERapy of Cancer), we explored the prognostic role of liquid biopsy encompassing cell-free DNA (cfDNA) and circulating tumour cells (CTCs) in KRAS mutated metastatic colorectal cancer...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Cancer
Auteurs principaux: Salvianti, Francesca, Gelmini, Stefania, Mancini, Irene, Pazzagli, Mario, Pillozzi, Serena, Giommoni, Elisa, Brugia, Marco, Di Costanzo, Francesco, Galardi, Francesca, De Luca, Francesca, Castiglione, Francesca, Messerini, Luca, Pinzani, Pamela, Antonuzzo, Lorenzo
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8257609/
https://ncbi.nlm.nih.gov/pubmed/33953347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01399-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires